Unicycive Therapeutics, Inc. (UNCY)
5.34
-0.29
(-5.15%)
USD |
NASDAQ |
Aug 24, 16:00
5.35
+0.01
(+0.19%)
After-Hours: 20:00
Unicycive Therapeutics Net Income (Quarterly) : -1.722M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.722M |
| March 31, 2026 | -12.82M |
| December 31, 2025 | -14.67M |
| September 30, 2025 | -6.011M |
| June 30, 2025 | -6.447M |
| March 31, 2025 | 0.51M |
| December 31, 2024 | -21.52M |
| September 30, 2024 | -4.096M |
| June 30, 2024 | 3.93M |
| March 31, 2024 | -20.96M |
| December 31, 2023 | -7.798M |
| September 30, 2023 | -4.333M |
| June 30, 2023 | -3.838M |
| March 31, 2023 | -14.58M |
| Date | Value |
|---|---|
| December 31, 2022 | -5.328M |
| September 30, 2022 | -5.557M |
| June 30, 2022 | -3.636M |
| March 31, 2022 | -3.537M |
| December 31, 2021 | -2.752M |
| September 30, 2021 | -5.201M |
| June 30, 2021 | -1.10M |
| March 31, 2021 | -0.964M |
| December 31, 2020 | -0.88M |
| September 30, 2020 | -0.702M |
| June 30, 2020 | -0.338M |
| March 31, 2020 | -0.344M |
| December 31, 2019 | -0.702M |
| September 30, 2019 | -0.564M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 51.29M |
| Theriva Biologics, Inc. | -3.217M |
| AbbVie, Inc. | 3.604B |
| Decoy Therapeutics, Inc. | -2.374M |
| Nkarta, Inc. | -40.37M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 1.722M |
| EPS Diluted (Quarterly) | -0.064 |
| Enterprise Value | 88.06M |
| Earnings Yield | -29.89% |
| Normalized Earnings Yield | -27.33 |